Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Apr 15, 2022; 14(4): 897-919
Published online Apr 15, 2022. doi: 10.4251/wjgo.v14.i4.897
Published online Apr 15, 2022. doi: 10.4251/wjgo.v14.i4.897
Figure 2 Survival curve analyses for patients and receiver operating characteristic curves of inflammatory indices.
A: Survival curves of all patients; B-D: Survival curves of patients with the expansive growth type (INFa), the intermediate type (INFb), and the infiltrative growth type (INFc); E-H: Receiver operating characteristic curve of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and systemic immune-inflammation index in all patients, INFa group, INFb group, and INFc group. INFa: The expansive growth type; INFb: The intermediate type; INFc: The infiltrative growth type; ROC: Receiver operating characteristic; NLR: Neutrophil-lymphocyte ratio; PLR: Platelet-lymphocyte ratio; SII: Systemic immune-inflammation index.
- Citation: Wang YF, Yin X, Fang TY, Wang YM, Zhang L, Zhang XH, Zhang DX, Zhang Y, Wang XB, Wang H, Xue YW. Prognostic significance of serum inflammation indices for different tumor infiltrative pattern types of gastric cancer. World J Gastrointest Oncol 2022; 14(4): 897-919
- URL: https://www.wjgnet.com/1948-5204/full/v14/i4/897.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i4.897